BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 35470074)

  • 1. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
    Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy.
    Li S; Zhao Y; Ma W; Wang D; Liu H; Wang W; Peng D; Yu CY; Wei H
    Acta Biomater; 2024 Jan; 173():389-402. PubMed ID: 37967695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH/GSH dual-responsive supramolecular nanomedicine for hypoxia-activated combination therapy.
    Du C; Wang C; Jiang SH; Zheng X; Li Z; Yao Y; Ding Y; Chen T; Yi H
    Biomater Sci; 2023 Aug; 11(16):5674-5679. PubMed ID: 37439102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo-Chemodynamic Combination Therapy.
    Zhu P; Luo W; Qian J; Meng C; Shan W; Xu Z; Zhang W; Liu X; Ling Y
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction.
    Liu X; Liu J; Meng C; Zhu P; Liu X; Qian J; Ling S; Zhang Y; Ling Y
    ACS Appl Mater Interfaces; 2021 Nov; 13(45):53574-53585. PubMed ID: 34729975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy.
    Wang Y; Zhang S; Wang J; Zhou Q; Mukerabigwi JF; Ke W; Lu N; Ge Z
    J Control Release; 2021 May; 333():500-510. PubMed ID: 33848558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Antitumor Efficacy by a Cascade of Reactive Oxygen Species Generation and Drug Release.
    Wang S; Yu G; Wang Z; Jacobson O; Lin LS; Yang W; Deng H; He Z; Liu Y; Chen ZY; Chen X
    Angew Chem Int Ed Engl; 2019 Oct; 58(41):14758-14763. PubMed ID: 31429173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSH-Responsive Organosilica Hybrid Nanosystem as a Cascade Promoter for Enhanced Starvation and Chemodynamic Therapy.
    Wu H; Li X; Liu S; Wang Q; Cao Y; Hao JN; Li Y
    Adv Healthc Mater; 2023 Jan; 12(2):e2201262. PubMed ID: 36213949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A versatile supramolecular nanoagent for three-pronged boosting chemodynamic therapy.
    Liu X; Liu J; Xu Q; Tao W; Xie X; Meng C; Zhou Q; Zhang Y; Ling Y
    J Colloid Interface Sci; 2023 Oct; 648():994-1005. PubMed ID: 37331080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment.
    Chen H; Xing C; Lei H; Yan B; Zhang H; Tong T; Guan Y; Kang Y; Pang J
    J Control Release; 2024 Apr; 368():637-649. PubMed ID: 38484895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-prodrug cascade activation for chemo/chemodynamic mutually beneficial combination cancer therapy.
    Zhang X; Guo H; Zhang X; Shi X; Yu P; Jia S; Cao C; Wang S; Chang J
    Biomater Sci; 2023 Jan; 11(3):1066-1074. PubMed ID: 36562486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
    Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
    ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-Delivering Nanocomplexes with Fenton Reaction-Triggered Cargo Release to Boost Cancer Immunotherapy.
    Li X; Zhou Q; Japir AAMM; Dutta D; Lu N; Ge Z
    ACS Nano; 2022 Sep; 16(9):14982-14999. PubMed ID: 36017992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphate-Degradable Nanoparticles Based on Metal-Organic Frameworks for Chemo-Starvation-Chemodynamic Synergistic Antitumor Therapy.
    Peng H; Qin YT; Feng YS; He XW; Li WY; Zhang YK
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):37713-37723. PubMed ID: 34340302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-responsive Mannose-modified ferrocene Metal-Organic frameworks with rare earth for Tumor-targeted synchronous Chemo/Chemodynamic therapy.
    Dong J; Ma K; Ding J; Pei Y; Pei Z
    Bioorg Med Chem; 2022 Sep; 69():116885. PubMed ID: 35752144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-amplified activatable nanoprodrugs for enhanced chemodynamic/chemo combination therapy.
    He X; Liu M; Du M; Huang Y; Xu P; Xie C; Fan Q; Zhou W
    Nanotechnology; 2024 Feb; 35(17):. PubMed ID: 38262050
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Huang S; Zhao N; Qian Z; Yuan W
    J Mater Chem B; 2023 Apr; 11(16):3727-3739. PubMed ID: 37067286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Pot Rapid Synthesis of Cu
    Li Q; Yu J; Lin L; Zhu Y; Wei Z; Wan F; Zhang X; He F; Tian L
    ACS Appl Mater Interfaces; 2023 Apr; 15(13):16482-16491. PubMed ID: 36972557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment responsive self-cascade catalysis for synergistic chemo/chemodynamic therapy by multifunctional biomimetic nanozymes.
    Zheng N; Fu Y; Liu X; Zhang Z; Wang J; Mei Q; Wang X; Deng G; Lu J; Hu J
    J Mater Chem B; 2022 Jan; 10(4):637-645. PubMed ID: 34991154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.